Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson’s disease

被引:0
作者
Domiziana Rinaldi
Lanfranco De Carolis
Francesco Ceriello
Edoardo Bianchini
Francesco E. Pontieri
机构
[1] Sapienza University of Rome,Department of Neuroscience, Mental Health and Sensory Organs
[2] Fondazione Santa Lucia,Department of Clinical and Behavioral Neurology
[3] IRCCS,undefined
来源
Neurological Sciences | 2022年 / 43卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4571 / 4572
页数:1
相关论文
共 14 条
  • [1] Skogar O(2016)Pain management in patients with Parkinson’s disease: challenges and solutions J Multidiscip Healthc 9 469-479
  • [2] Lokk J(2021)The long-term impact of levodopa/carbidopa intestinal gel on “off” time in patients with advanced Parkinson’s disease: a systematic review Adv Ther 38 2854-2890
  • [3] Antonini A(2018)Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach Curr Med Res Opin 34 2063-2073
  • [4] Odin P(2021)24-hour levodopa-carbidopa intestinal gel: clinical experience and practical recommendations CNS Drugs 35 137-149
  • [5] Pahwa R(2020)Application of the “5-2-1” screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE Neurodegen Dis Manag 10 309-323
  • [6] Antonini A(undefined)undefined undefined undefined undefined-undefined
  • [7] Stoessl AJ(undefined)undefined undefined undefined undefined-undefined
  • [8] Kleinman LS(undefined)undefined undefined undefined undefined-undefined
  • [9] Thakkar S(undefined)undefined undefined undefined undefined-undefined
  • [10] Fung VSC(undefined)undefined undefined undefined undefined-undefined